As a surgeon with specialty training in surgical oncology, I care for patients with benign and malignant (cancerous) diseases of the liver, gallbladder, bile ducts, and pancreas, as well as cancer that has spread (metastasized) to the liver from the colon.
I am one of seven board-certified surgeons here at Memorial Sloan-Kettering who specializes in treating these diseases, and together we perform between 800 and 1,000 cancer-related operations every year. Our team works very closely with colleagues in medical oncology, radiation oncology, radiology, gastroenterology, nursing, and other specialties to provide the very best, individualized care for our patients.
One of my main goals as a surgeon is to find more-effective ways to remove liver and pancreas tumors through techniques that are considered “minimally invasive” – so that the physical stress on the body and the amount of time it takes for my patients to recover from an operation can be reduced. Advances in laparoscopic and robotic surgical approaches have helped make this happen, and many of these techniques were originally developed here at Memorial Sloan-Kettering. That said, we are always looking for even more ways to reduce the impact of surgery on our patients, including using heat and cold to kill tumors through an approach called image-guided ablation.